Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2007-03-27
2007-03-27
Campell, Bruce R. (Department: 1648)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C435S320100, C435S069100, C435S091100, C435S091400, C514S184000
Reexamination Certificate
active
09705149
ABSTRACT:
Methods of eliciting an immune response in a subject by administering one or more large genomic DNA fragments are provided. Also provided are methods of identifying sequences encoding antigenic polypeptides. Also provided are vaccine compositions comprising one or more large genomic DNA fragments.
REFERENCES:
patent: 4629782 (1986-12-01), Chan et al.
patent: 4945050 (1990-07-01), Sanford et al.
patent: 4980286 (1990-12-01), Morgan et al.
patent: 4981782 (1991-01-01), Judd et al.
patent: 5036006 (1991-07-01), Sanford et al.
patent: 5091188 (1992-02-01), Haynes
patent: 5100792 (1992-03-01), Sanford et al.
patent: 5120657 (1992-06-01), McCabe et al.
patent: 5149655 (1992-09-01), McCabe et al.
patent: 5171568 (1992-12-01), Burke et al.
patent: 5179022 (1993-01-01), Sanford et al.
patent: 5204253 (1993-04-01), Sanford et al.
patent: 5219740 (1993-06-01), Miller et al.
patent: 5371015 (1994-12-01), Sanford et al.
patent: 5378814 (1995-01-01), Houghton et al.
patent: 5478744 (1995-12-01), Sanford et al.
patent: 5584807 (1996-12-01), McCabe
patent: 5589466 (1996-12-01), Felgner et al.
patent: 5630796 (1997-05-01), Bellhouse et al.
patent: 5658892 (1997-08-01), Flotte et al.
patent: 5738652 (1998-04-01), Boyd et al.
patent: 5851826 (1998-12-01), Fraefel et al.
patent: 5865796 (1999-02-01), McCabe
patent: 5899880 (1999-05-01), Bellhouse et al.
patent: 6004286 (1999-12-01), Bellhouse et al.
patent: 6010478 (2000-01-01), Bellhouse et al.
patent: 6013050 (2000-01-01), Bellhouse et al.
patent: 6168587 (2001-01-01), Bellhouse et al.
patent: 6194389 (2001-02-01), Johnston et al.
patent: 6573090 (2003-06-01), Breakefield et al.
patent: 6642207 (2003-11-01), Horsburgh et al.
patent: 0213894 (1987-03-01), None
patent: 0390435 (1990-10-01), None
patent: WO 89/04669 (1989-06-01), None
patent: WO 89/05349 (1989-06-01), None
patent: WO 90/01949 (1990-03-01), None
patent: WO 90/11089 (1990-10-01), None
patent: WO 90/14436 (1990-11-01), None
patent: WO 91/00359 (1991-01-01), None
patent: WO 91/07487 (1991-05-01), None
patent: WO 93/19183 (1993-09-01), None
patent: WO 94/00575 (1994-01-01), None
patent: WO 94/09819 (1994-05-01), None
patent: WO 94/21797 (1994-09-01), None
patent: WO 94/24263 (1994-10-01), None
patent: WO 95/16779 (1995-06-01), None
patent: WO 95/19799 (1995-07-01), None
patent: WO 95/20660 (1995-08-01), None
patent: WO 96/04947 (1996-02-01), None
patent: WO 96/12513 (1996-05-01), None
patent: WO 96/14855 (1996-05-01), None
patent: WO 96/20022 (1996-07-01), None
patent: WO 96/31613 (1996-10-01), None
patent: WO 97/32987 (1997-09-01), None
patent: WO 97/40163 (1997-10-01), None
patent: WO 97/48485 (1997-12-01), None
patent: WO 98/10750 (1998-03-01), None
patent: WO 98/46263 (1998-10-01), None
patent: WO 99/31262 (1999-06-01), None
patent: WO 99/43842 (1999-09-01), None
Braun et al. Virology, 1999, vol. 265, pp. 46-45.
Tacket et al. Vaccine 1999, vol. 17, pp. 2826-2829.
Ladmell et al. Vaccine 1998, vol. 16, pp. 115-118.
Haynes et al. AIDS Research and Human Retroviruses 1994, vol. 10, pp. S43-S45.
Webster et al. Vaccine 1994, vol. 12, pp. 1495-1498.
Macklin et al. Journal of Virology 1998, vol. 72, pp. 1491-1496.
Fynan et al. P.N.A.S. U.S.A. 1993, vol. 90, pp. 11478-11482.
Barry et al. Vaccine 1997, vol. 15, pp. 788-791.
Pertmer et al. Vaccine 1995, vol. 15, pp. 1427-1430.
Boer JG et al. Carcinogenesis. 1992, vol. 13, pp. 15-17.
Reid et al. Environ Health Perspect. Sep. 1994;102 Suppl 3:57-61.
Suter et al. Vaccine 1999, vol. 96, No. 22, pp. 12697-13702.
Hilliard et al. Arch Virol. 1989, vol. 109, No. 1-2, pp. 83-102.
Samaniego et al. J. Virol. 1998, vol. 72, No. 4, pp. 3307-3320.
Watnabe et al. Virol. Sep. 20, 2006, No. 1, pp. 1-13.
Baer et al. (1984)Nature310:207-211.
Davison et al. (1986)J. Gen. Virol. 67:1759-1816.
Stanberry et al. (1987)J. Infect. Dis. 155:914-920.
McGeoch et al. (1988)J. Gen. Virol. 69:1531-1574.
Stanberry et al. (1988)J. Infect. Dis. 157:156-163.
Ho et al. (1989)J. Virol. 63:2951-2958.
Burke et al. (1991)Virology181:793-797.
Burke et al. (1991)Rev. Infect. Dis. 13(Suppl 11):S906-S911.
Houghton et al. (1991)Hepatology14:381-388.
Mertz et al. (1992)Ann. Intern. Med. 116:197-202.
Straus et al. (1994)Lancet343:1460-1463.
Johnston et al. (1997)Vaccine15:808-809.
Swain et al. (1997)Behring Institute98:73-78.
Remington's Pharmaceutical Sciences (1980) Mark Publishing Company, Pennsylvania, pp. 1483-1484.
Townsend et al. (1984) Cell 39: pp. 13-25.
Townsend et al. (1985) Prog. Allergy 36: pp. 10-43.
Sanford et al. (1987) Particulate Science and Technology 5: pp. 27-37.
Klein et al. (1987) Nature 327: pp. 70-73.
Tang et al. (1988) J. Virology 62:4745-4751.
Zelenin et al. (1989) FEBS Letters 244: pp. 65-67.
Milich (1989) Advances in immunology 45: pp. 195-282.
S.A. Johnston (1990) “Biolistic transformation: microbes to mice,” Nature 346: pp. 776-777.
Poznansky et al. (1991) J. Virology 65: pp. 532-536.
Haynes et al. (1991) Molecular Immunology 28: pp. 231-234.
Rhim et al. (1991) J. Virology 65: pp. 4555-4564.
Rousseaux-Prevost et al. (1991) Molecular Immunology 28: pp. 943-949.
Sedegah et al. (1994) Proc. Natl. Acad. Sci. USA 91: pp. 9866-9870.
Fynan et al. (1995) Int. J. Immunopharmac. 17: pp. 79-83.
Sarphie et al. (1997) J. Controlled Release 47: pp. 61-69.
Suter et al. (1999) Proc. Natl. Acad. Sci. USA 96: pp. 12697-12702.
Rippie, E.G., Ph.D. (1980) Pharmaceutical Sciences, Marck Publishing Company, Pennsylvania, pp. 1535-1552.
Saeki et al., “Herpes Simplex Virus Type 1 DNA Amplified as Bacterial Artificial Chromosome inEscherichia coli: Rescue of Replication-Competent Virus Progeny and Packaging of Amplicon Vectors,”Human Gene Therapy9:2787-2794 (1998).
Braun Ralph P.
Payne Lendon G.
Roberts Lee K.
Swain William F.
Campell Bruce R.
Li Bao Qun
Powderject Vaccines, Inc.
LandOfFree
DNA-vaccines based on constructs derived from the genomes of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with DNA-vaccines based on constructs derived from the genomes of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DNA-vaccines based on constructs derived from the genomes of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3774660